IRIDEX Corporation (IRIX) Investor Relations Documents

IRIDEX Corporation (IRIX) investor relations documents from the company's IR site: 1 presentation, 35 press releases; latest deck 2026-06-01. Read in-app with summaries. First-party data.

Investor Presentation May 2026 — IRIDEX investor presentation shows $53M FY25A revenue and highlights its retina and glaucoma laser technology portfolios, with a focus on MicroPulse technology.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-18Press releaseIridex Reports Second Quarter 2026 Financial Results
2026-08-04Press releaseIridex to Report Second Quarter 2026 Financial Results on August 18, 2026
2026-07-20Press releaseIridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
2026-06-09Press releaseIridex to Present at the Planet MicroCap Las Vegas 2026 Conference
2026-06-01PresentationInvestor Presentation May 2026
2026-05-19Press releaseIridex Reports First Quarter 2026 Financial Results
2026-05-05Press releaseIridex to Report First Quarter 2026 Financial Results on May 19, 2026
2026-04-07Press releaseIridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
2026-03-26Press releaseIridex Reports Fourth Quarter and Full Year 2025 Financial Results
2026-03-12Press releaseIridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
2026-02-02Press releaseIridex Announces Plans to Relocate Headquarters
2026-01-12Press releaseIridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
2025-12-11Press releaseIridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral
2025-12-08Press releaseIridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Tec
2025-12-05Press releaseIridex to Present at the Sidoti Year-End Virtual Investor Conference
2025-11-11Press releaseIridex Reports Third Quarter 2025 Financial Results
2025-10-28Press releaseIridex to Report Third Quarter 2025 Financial Results on November 11, 2025
2025-09-09Press releaseIridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
2025-06-24Press releaseIridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Tech
2025-04-09Press releaseIridex to Host Strategic Vision Call on April 16, 2025
2025-03-27Press releaseIridex Reports Fourth Quarter and Full Year 2024 Financial Results
2025-03-19Press releaseIridex Announces Strategic Investment in the Company
2025-03-14Press releaseIridex Comments on Recent Stock Price Volatility
2025-03-13Press releaseIridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
2025-01-14Press releaseIridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
2024-11-12Press releaseEarnings Release
2024-08-08Press releaseEarnings Release
2024-05-14Press releaseEarnings Release
2024-03-26Press releaseEarnings Release
2023-11-14Press releaseEarnings Release
2023-08-10Press releaseEarnings Release
2023-05-11Press releaseEarnings Release
2023-03-09Press releaseEarnings Release
2022-11-10Press releaseEarnings Release
2022-08-15Press releaseEarnings Release
2022-05-12Press releaseEarnings Release

IRIX overview · IRIX earnings · IRIX financials · IRIX KPIs · IRIX ownership · IRIX peers · IRIX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.